Bioteque (ROCO:4107) 5-Year Yield-on-Cost %: 5.95 (As of Aug. 21, 2026) — 37% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4107 Bioteque Corp ROCO:4107
84 GF Score
Price NT$114.00
GF Value NT$130.42
Valuation Modestly Undervalued
View Full Analysis

What is Bioteque 5-Year Yield-on-Cost %?

Bioteque ROCO:4107 -0.44% 84 5-Year Yield-on-Cost % is 5.95 as of Aug. 21, 2026, which is 37% above its 10-year median of 4.33. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$130.42 (Modestly Undervalued). Among 315 Medical Devices & Instruments companies, Bioteque ranks better than 80.95% on this metric.

Bioteque's yield on cost for the quarter that ended in Jun. 2026 was 5.95.


The historical rank and industry rank for Bioteque's 5-Year Yield-on-Cost % or its related term are showing as below:

ROCO:4107' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.9   Med: 4.33   Max: 5.95
Current: 5.95


During the past 13 years, Bioteque's highest Yield on Cost was 5.95. The lowest was 1.90. And the median was 4.33.


ROCO:4107's 5-Year Yield-on-Cost % is ranked better than
80.95% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 2.4 vs ROCO:4107: 5.95

Bioteque  (ROCO:4107) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Bioteque 5-Year Yield-on-Cost % Related Terms


ROCO:4107 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison

For the Medical Instruments & Supplies subindustry, Bioteque's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioteque 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Bioteque's 5-Year Yield-on-Cost % falls into.


ROCO:4107
84GF Score
Bioteque Corp ROCO:4107
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioteque 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Bioteque is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 5.95 mean?
Bioteque (ROCO:4107) has a 5-Year Yield-on-Cost % of 5.95 as of Aug. 21, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bioteque and its competitors. This is 37% above median its historical median of 4.33. Over the past decade, Bioteque's 5-Year Yield-on-Cost % has ranged from 1.90 to 5.95. According to the industry distribution chart, Bioteque ranks #60 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is Bioteque's 5-Year Yield-on-Cost % too high?
Bioteque's current 5-Year Yield-on-Cost % of 5.95 is 37% above median its 10-year median of 4.33. Over the past 10 years, this metric has ranged from a low of 1.90 to a high of 5.95. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.40. Bioteque's value of 5.95 is 147.9% above this industry median. Based on the distribution chart, Bioteque ranks #60 out of 315 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bioteque has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #60 out of 315 companies for 5-Year Yield-on-Cost %. This places Bioteque in the top 19% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.40. Bioteque's value of 5.95 is 147.9% above this benchmark. Historically, Bioteque's own 5-Year Yield-on-Cost % has ranged from 1.90 to 5.95 over the past decade. While the company's 10-year median is 4.33 vs. the industry median of 2.40, Bioteque has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.40, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioteque's current 5-Year Yield-on-Cost % of 5.95 is 147.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Bioteque and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioteque's current 5-Year Yield-on-Cost % is 5.95, which is 37% above median its own 10-year median of 4.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$130.42, compared to a current price of NT$114.00 — trading 12.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 5.95, which is 37% above median its 10-year median of 4.33 and 147.9% above the Medical Devices & Instruments industry median of 2.40. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current 5-Year Yield-on-Cost % is 5.95 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bioteque (ROCO:4107) Overvalued in 2026?

Based on GuruFocus' analysis, Bioteque stock appears to be undervalued. The current stock price of NT$114.00 is trading 12.6% below its estimated GF Value™ of NT$130.42. GuruFocus considers Bioteque to be Modestly Undervalued.

Key valuation signals for ROCO:4107:

  • 5-Year Yield-on-Cost %: 5.95 (37% above median its 10-year median of 4.33)
  • GF Value™: NT$130.42 vs. price of NT$114.00 (12.6% below fair value)
  • GF Score™: 84/100
  • Industry Position: 147.9% above the Medical Devices & Instruments median (#60 of 315)

No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bioteque Business Description

Address Chang-An E. Road, 5th Floor-6, No.23, Section 1, Taipei, TWN, 104
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score

Get the complete analysis for ROCO:4107

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$114.00
Price
NT$130.42
GF Value